Skip to main content
SpringerLink
Log in

Rezidivierendes oder refraktäres multiples Myelom

Wirksamkeit von Anti-BCMA-CAR-T-Zellen

  • Journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Munshi NC et al. N Engl J Med. 2021;384(8):705-16

  2. Devarakonda S et al. Cancers (Basel). 2021;13(4):863

  3. Kerbage F et al. Clin Lymphoma Myeloma Leuk. 2020;20(4):209-11

  4. Lonial S et al. Lancet Oncol. 2020;21(2):207-21

  5. Raje N et al. N Engl J Med. 2019;380(18):1726-37

  6. https://seer.cancer.gov/statfacts/html/mulmy.html abgerufen am 19. April 2021

Download references

Author information

Authors and Affiliations

  1. Abteilung für klinische Pharmakologie, Klinikum Innenstadt der Universität München, Lindwurmstr. 2 A, 80337, München, Deutschland

    Sebastian Kobold

Authors
  1. Sebastian Kobold
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sebastian Kobold.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kobold, S. Wirksamkeit von Anti-BCMA-CAR-T-Zellen. InFo Hämatol Onkol 24, 28–29 (2021). https://doi.org/10.1007/s15004-021-8660-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-021-8660-4

Search

Navigation